Vasopressin Effects on Human Social Communication

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This research is being done because we wish to understand how a chemical produced in the brain, vasopressin, effects emotional social communication processes. Understanding how this system works in normal individuals may help us understand why some people, particularly those with autism and/or antisocial personality disorder, have dysfunctional social interactions. This study will test the effects of 3 doses of arginine vasopressin, delivered intranasally, on physiological and behavioral responses to the faces of same- and other-sex individuals in healthy men and women.

Key facts

Study ID

NCT01327027

Run by

Bowdoin College

People needed

225

Starts

2011-09-01

Expected to finish

2017-04-01

Last updated by the study team

2017-11-06

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men and women 21-30 years of age

You may not qualify if…

• individuals with high blood pressure or a history of seizures
• allergies
• heart problems
• psychiatric problems
• drug abuse
• pregnant All subjects will be given a preliminary medical and psychiatric exam as well as drug and (for women) pregnancy test

Where it is running

• Maine Medical Center, McGeachey Hall, OP Psych — Portland, Maine, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.